Published in
Elsevier, The Lancet, 9992(386), p. 444-451
DOI: 10.1016/s0140-6736(15)60898-4
Links
Tools
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: A multicentre, double-blind, phase 3 randomised controlled trial
Journal article published in 2015 by
Georgina V. Long,
Daniil Stroyakovskiy,
Helen Gogas,
Evgeny Levchenko,
Filippo de Braud,
James Larkin,
Claus Garbe 
,
Thomas Jouary,
Axel Hauschild,
Jean-Jacques Grob,
Vanna Chiarion-Sileni,
Celeste Lebbe,
Mario Mandalà,
Michael Millward,
Ana Arance
and other authors.
,
Thomas Jouary,
Axel Hauschild,
Jean-Jacques Grob,
Vanna Chiarion-Sileni,
Celeste Lebbe,
Mario Mandalà,
Michael Millward,
Ana Arance
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 